<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reflux of gastric contents can lead to development of reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a risk factor for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Damage to DNA may lead to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> but is repaired through activation of pathways involving polymorphic enzymes, including human <z:chebi fb="0" ids="44605">8-oxoguanine</z:chebi> glycosylase 1 (hOGG1), X-ray repair cross-complementing 1 (XRCC1), and <z:e sem="disease" ids="C0043346" disease_type="Neoplastic Process" abbrv="">xeroderma pigmentosum</z:e> group D (<z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Of the single nucleotide polymorphisms identified in these genes, hOGG1 Ser 326 Cys, XRCC1 Arg 399 Gln, and <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e> Lys 751 Gln are particularly common in Caucasians and have been associated with lower DNA repair capacity </plain></SENT>
<SENT sid="4" pm="."><plain>Small studies have reported associations with <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e> Lys 751 Gln and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>XRCC1 Arg 399 Gln has been linked to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In a population-based case-control study, we examined associations of the hOGG1 Ser 326 Cys, XRCC1 Arg 399 Gln, and <z:e sem="disease" ids="C0268138" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPD</z:e> Lys 751 Gln polymorphisms with risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Genomic DNA was extracted from blood samples collected from cases of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 210), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (n = 212), reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 230), and <z:mpath ids='MPATH_458'>normal</z:mpath> population controls frequency matched for age and sex (n = 248) </plain></SENT>
<SENT sid="8" pm="."><plain>Polymorphisms were genotyped using TaqMan allelic discrimination assays </plain></SENT>
<SENT sid="9" pm="."><plain>Odds ratios and 95% confidence intervals were obtained from logistic regression models adjusted for potential confounding factors </plain></SENT>
<SENT sid="10" pm="."><plain>There were no statistically significant associations between these polymorphisms and risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, or reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
</text></document>